Flputnam Investment Management Co. Acquires New Holdings in AirSculpt Technologies, Inc. $AIRS

Key Points

• Flputnam Investment Management acquired 691,989 AirSculpt Technologies shares worth approximately $3.1 million, giving it a 0.98% stake. Institutional investors collectively own 91.54% of the company.
• AirSculpt reported quarterly revenue of $42.9 million and earnings of $0.01 per share, both slightly below analyst expectations. The company posted a negative net margin of 7.79%.
• AIRS opened at $3.43, below the consensus price target of $4.50. Analyst sentiment remains cautious, with one Hold and one Sell rating producing a consensus recommendation of “Reduce.”

Flputnam Investment Management Co. bought a new stake in shares of AirSculpt Technologies, Inc. (NASDAQ:AIRS - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 691,989 shares of the company's stock, valued at approximately $3,114,000. Flputnam Investment Management Co. owned approximately 0.98% of AirSculpt Technologies at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AIRS. BNP Paribas Financial Markets grew its position in shares of AirSculpt Technologies by 239.5% in the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company's stock valued at $48,000 after purchasing an additional 4,199 shares during the last quarter. Royal Bank of Canada raised its position in shares of AirSculpt Technologies by 259.6% during the 1st quarter. Royal Bank of Canada now owns 9,879 shares of the company's stock worth $28,000 after purchasing an additional 7,132 shares during the last quarter. Intech Investment Management LLC acquired a new position in shares of AirSculpt Technologies during the 3rd quarter worth approximately $80,000. Brevan Howard Capital Management LP purchased a new stake in AirSculpt Technologies in the 3rd quarter valued at approximately $83,000. Finally, Jane Street Group LLC purchased a new stake in AirSculpt Technologies in the 2nd quarter valued at approximately $60,000. Institutional investors and hedge funds own 91.54% of the company's stock.

AirSculpt Technologies Stock Performance

Shares of AirSculpt Technologies stock opened at $3.43 on Monday. AirSculpt Technologies, Inc. has a fifty-two week low of $1.51 and a fifty-two week high of $12.00. The business's fifty day moving average is $4.53 and its two-hundred day moving average is $3.57. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.32. The firm has a market cap of $247.30 million, a PE ratio of -19.05 and a beta of 2.33.

AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The company reported $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.01). AirSculpt Technologies had a negative net margin of 7.79% and a negative return on equity of 5.83%. The business had revenue of $42.90 million during the quarter, compared to analysts' expectations of $44.14 million.

Analyst Upgrades and Downgrades

Several research firms have weighed in on AIRS. Weiss Ratings raised AirSculpt Technologies from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Wednesday, July 1st. Leerink Partners set a $4.50 price objective on AirSculpt Technologies in a research report on Thursday, May 14th. Finally, Wall Street Zen downgraded AirSculpt Technologies from a "buy" rating to a "hold" rating in a research report on Saturday. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, AirSculpt Technologies has a consensus rating of "Reduce" and an average price target of $4.50.

AirSculpt Technologies Profile

AirSculpt Technologies, Inc NASDAQ: AIRS is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source